Compare · ELV vs LMRI
ELV vs LMRI
Side-by-side comparison of Elevance Health Inc. (ELV) and Lumexa Imaging Holdings Inc. (LMRI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and LMRI operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 89.7x LMRI ($1.04B).
- ELV has been more active in the news (3 items in the past 4 weeks vs 2 for LMRI).
- ELV has more recent analyst coverage (23 ratings vs 11 for LMRI).
- Company
- Elevance Health Inc.
- Lumexa Imaging Holdings Inc.
- Price
- -
- -
- Market cap
- $92.91B
- $1.04B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 3
- 2
- Recent ratings
- 23
- 11
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
Latest LMRI
- Truist initiated coverage on Lumexa Imaging Holdings with a new price target
- KeyBanc Capital Markets initiated coverage on Lumexa Imaging Holdings with a new price target
- Lumexa Imaging Announces Participation in Upcoming Investor Conferences
- SEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.
- SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure
- Lumexa Imaging Announces Second Quarter 2026 Results
- Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
- Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- Director Mittl Robert Louis Jr. was granted 19,358 shares (SEC Form 4)